Sanguine BioSciences' Series A Round

Sanguine BioSciences raised a round of funding on November 25, 2014.

Sanguine BioSciences is a biotechnology company bridging the gap between patients and researchers by providing transparency throughout the personalized medicine R&D process. Sanguine collects and de-i…

Articles about Sanguine BioSciences' Series A Round: